✦ LIBER ✦

PMH25 A COMPARISON OF THE COST-EFFECTIVENESS OF OLANZAPINE FOR THE TREATMENT OF SCHIZOPHRENIA IN SELECTED NON-OECD COUNTRIES

✍ Scribed by P Davey; N Price; M Lees; L Birinyi-Strachan; K Makino; M Mudge

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH3 A COST-EFFECTIVENESS COMPARISON OF

✍ S Beard; M Lothgren; L Giudi; F Ramacciotti; M Nardini; D Berardi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PMH48 VALIDATING A COST-EFFECTIVENESS AN

✍ C Graham; J Mauskopf; AH Lawson; H Ascher-Svanum; D Bruhn; PR Watson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH35 COST-EFFECTIVENESS OF ORALLY DISSO

✍ H Ascher-Svanum; NM Furiak; RW Klein; LJ Smolen; PR Watson; AH Lawson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH16 COST EFFECTIVENESS MODEL COMPARING

✍ B Ozsogut; M Saylan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMH10 COST AND EFFECTIVENESS OF SWITCHIN

✍ NA Thomas; D Faries; H Ascher-Svanum; AW Nyhuis; BJ Kinon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PMH35 A Cost-Effectiveness Analysis of P

✍ T.R. Einarson; C. Vicente; R. Zilbershtein; C. Piwko 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB